MyFinsight
Home
About
Contact
coya: the income statement
Download
Download image
Net loss
-$2,115,831
(47.39%↑ Y/Y)
Other income
$317,066
(-26.07%↓ Y/Y)
Collaboration revenue
$3,564,254
Depreciation
$6,840
(-0.01%↓ Y/Y)
Total general and
administrative expenses
$2,557,440
(15.22%↑ Y/Y)
In-process research and
development
$515,996
Total research and
development expenses
$2,916,875
(31.16%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)